ITB3_HUMAN - dbPTM
ITB3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ITB3_HUMAN
UniProt AC P05106
Protein Name Integrin beta-3
Gene Name ITGB3
Organism Homo sapiens (Human).
Sequence Length 788
Subcellular Localization Cell membrane
Single-pass type I membrane protein . Cell projection, lamellipodium membrane . Cell junction, focal adhesion .
Protein Description Integrin alpha-V/beta-3 (ITGAV:ITGB3) is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Integrin alpha-IIb/beta-3 (ITGA2B:ITGB3) is a receptor for fibronectin, fibrinogen, plasminogen, prothrombin, thrombospondin and vitronectin. Integrins alpha-IIb/beta-3 and alpha-V/beta-3 recognize the sequence R-G-D in a wide array of ligands. Integrin alpha-IIb/beta-3 recognizes the sequence H-H-L-G-G-G-A-K-Q-A-G-D-V in fibrinogen gamma chain. Following activation integrin alpha-IIb/beta-3 brings about platelet/platelet interaction through binding of soluble fibrinogen. This step leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. Fibrinogen binding enhances SELP expression in activated platelets (By similarity). ITGAV:ITGB3 binds to fractalkine (CX3CL1) and acts as its coreceptor in CX3CR1-dependent fractalkine signaling. [PubMed: 23125415]
Protein Sequence MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESIEFPVSEARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDLSYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDMKTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRNDASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLSQKNINLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVGFKDSLIVQVTFDCDCACQAQAEPNSHRCNNGNGTFECGVCRCGPGWLGSQCECSEEDYRPSQQDECSPREGQPVCSQRGECLCGQCVCHSSDFGKITGKYCECDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSNGLLCSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDRGALHDENTCNRYCRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
61PhosphorylationDEALPLGSPRCDLKE
CCCCCCCCCCCCCCC
19.4920562096
67UbiquitinationGSPRCDLKENLLKDN
CCCCCCCCCCCCCCC
31.1629967540
100PhosphorylationRPLSDKGSGDSSQVT
CCCCCCCCCCHHHCE
45.2128270605
103PhosphorylationSDKGSGDSSQVTQVS
CCCCCCCHHHCEEEC
26.6228270605
104PhosphorylationDKGSGDSSQVTQVSP
CCCCCCHHHCEEECC
33.1528270605
107PhosphorylationSGDSSQVTQVSPQRI
CCCHHHCEEECCCEE
18.6728270605
110PhosphorylationSSQVTQVSPQRIALR
HHHCEEECCCEEEEE
12.9028787133
125N-linked_GlycosylationLRPDDSKNFSIQVRQ
ECCCCCCCEEEEEEE
39.5916263699
127PhosphorylationPDDSKNFSIQVRQVE
CCCCCCEEEEEEEEC
22.8527794612
208PhosphorylationNPCYDMKTTCLPMFG
CCCCCCCCCEECCCC
18.99-
221PhosphorylationFGYKHVLTLTDQVTR
CCCCEEEEHHHHHHH
26.9028060719
223PhosphorylationYKHVLTLTDQVTRFN
CCEEEEHHHHHHHCC
21.1028060719
227PhosphorylationLTLTDQVTRFNEEVK
EEHHHHHHHCCHHHH
24.74-
346N-linked_GlycosylationNVVNLYQNYSELIPG
HHHHHHHHHHHHCCC
28.8311546839
397N-linked_GlycosylationEELSLSFNATCLNNE
CHHEEEEEEEECCCC
30.8511546839
422PhosphorylationLKIGDTVSFSIEAKV
CCCCCEEEEEEEEEE
18.5028634298
424PhosphorylationIGDTVSFSIEAKVRG
CCCEEEEEEEEEECC
16.4128634298
439PhosphorylationCPQEKEKSFTIKPVG
CCCCCCCCEEEECCC
28.81-
441PhosphorylationQEKEKSFTIKPVGFK
CCCCCCEEEECCCCC
34.87-
478N-linked_GlycosylationSHRCNNGNGTFECGV
CCCCCCCCCEEECCE
48.7517660510
585N-linked_GlycosylationDWTGYYCNCTTRTDT
CCCCEECCCCCCCCC
15.2811546839
611PhosphorylationRGKCECGSCVCIQPG
CCCEECCCEEEECCC
18.2928387310
619PhosphorylationCVCIQPGSYGDTCEK
EEEECCCCCCCCCCC
32.4028387310
623PhosphorylationQPGSYGDTCEKCPTC
CCCCCCCCCCCCCCC
20.4328387310
660PhosphorylationDENTCNRYCRDEIES
CCCHHHHHCHHHHHH
4.28-
667PhosphorylationYCRDEIESVKELKDT
HCHHHHHHHHHHHHC
44.1228060719
669UbiquitinationRDEIESVKELKDTGK
HHHHHHHHHHHHCCC
67.6129967540
680N-linked_GlycosylationDTGKDAVNCTYKNED
HCCCCCCCCEECCCC
17.7111546839
767PhosphorylationRARAKWDTANNPLYK
HHHHHHCCCCCHHHH
30.1229970186
773PhosphorylationDTANNPLYKEATSTF
CCCCCHHHHCHHHCC
14.1911723131
777PhosphorylationNPLYKEATSTFTNIT
CHHHHCHHHCCCCCE
29.4129255136
778O-linked_GlycosylationPLYKEATSTFTNITY
HHHHCHHHCCCCCEE
28.6822530207
778PhosphorylationPLYKEATSTFTNITY
HHHHCHHHCCCCCEE
28.6829255136
779PhosphorylationLYKEATSTFTNITYR
HHHCHHHCCCCCEEC
30.0829255136
781PhosphorylationKEATSTFTNITYRGT
HCHHHCCCCCEECCC
26.2929255136
784O-linked_GlycosylationTSTFTNITYRGT---
HHCCCCCEECCC---
14.8322530201
784PhosphorylationTSTFTNITYRGT---
HHCCCCCEECCC---
14.8328060719
785PhosphorylationSTFTNITYRGT----
HCCCCCEECCC----
11.8411546839
788PhosphorylationTNITYRGT-------
CCCEECCC-------
26.8328857561

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
773YPhosphorylationKinaseSRCP12931
PSP
773YPhosphorylationKinaseSRC64-PhosphoELM
777TPhosphorylationKinasePDK1Q15118
GPS
777TPhosphorylationKinasePDPK1O15530
PhosphoELM
779TPhosphorylationKinaseAKT1P31749
Uniprot
779TPhosphorylationKinasePDK1Q15118
GPS
779TPhosphorylationKinasePDK1O15530
PSP
779TPhosphorylationKinaseAKT-FAMILY-GPS
785YPhosphorylationKinaseSYKP43405
GPS
785YPhosphorylationKinaseSRCP12931
PSP
785YPhosphorylationKinaseSYKQ15046
PhosphoELM
785YPhosphorylationKinaseSRC64-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
779TPhosphorylation

10896934

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ITB3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ITAV_HUMANITGAVphysical
11884718
FAK1_HUMANPTK2physical
11927607
CENPR_HUMANITGB3BPphysical
11864709
PECA1_HUMANPECAM1physical
10982404
FAK1_HUMANPTK2physical
9169439
PGFRB_HUMANPDGFRBphysical
10964931
TLN1_HUMANTLN1physical
11932255
CENPR_HUMANITGB3BPphysical
7593198
PGFRA_HUMANPDGFRAphysical
11953315
KSYK_HUMANSYKphysical
11042121
TSP1_HUMANTHBS1physical
14963009
EPHA2_HUMANEPHA2physical
23874206
ITA5_HUMANITGA5physical
22470492
PDIA1_HUMANP4HBphysical
21670307
PA24A_HUMANPLA2G4Aphysical
18840708
VIME_HUMANVIMphysical
18840708
KPCB_HUMANPRKCBphysical
18840708
SHC1_HUMANSHC1physical
19889638
FAK1_HUMANPTK2physical
19889638
VGFR2_HUMANKDRphysical
25644401
ITA4_HUMANITGA4physical
25792870
ITAV_HUMANITGAVphysical
25792870
ITB1_HUMANITGB1physical
25792870
ITA2B_HUMANITGA2Bphysical
9351872
GCN4_YEASTGCN4physical
11412103
ITA2B_HUMANITGA2Bphysical
15219201
CIB1_HUMANCIB1physical
24163826
SHC1_HUMANSHC1physical
10896934
FINC_HUMANFN1physical
11478883
FIBG_HUMANFGGphysical
16877710
ITAV_HUMANITGAVphysical
10891446
ITA2B_HUMANITGA2Bphysical
10891446

Drug and Disease Associations
Kegg Disease
H00083 Allograft rejection
H00226 Glanzmann thrombasthenia
OMIM Disease
273800Glanzmann thrombasthenia (GT)
187800Bleeding disorder, platelet-type 16 (BDPLT16)
Kegg Drug
D01029 Tirofiban hydrochloride (USAN); Tirofiban hydrochloride hydrate; Aggrastat (TN)
D02778 Abciximab (genetical recombination) (JAN); Abciximab (USAN/INN); Reopro (TN)
D03497 Cilengitide (USAN/INN)
D03971 Elarofiban (USAN)
D04659 Lamifiban (USAN/INN)
D04660 Lamifiban hydrochloride (USAN)
D04785 Lotrafiban hydrochloride (USAN)
D05267 Orbofiban acetate (USAN)
D05772 Roxifiban acetate (USAN)
D05834 Sibrafiban (USAN/INN)
D06335 Xemilofiban hydrochloride (USAN)
D06649 Tadocizumab (USAN)
D06888 Eptifibatide (INN); Integrilin (TN)
D08607 Tirofiban (INN); Agrastat (TN)
D09342 Etaracizumab (USAN/INN); Abegrin (TN)
D09903 Fluciclatide F 18 (USAN/INN)
D09929 Maraciclatide (USAN/INN)
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ITB3_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-680, AND MASSSPECTROMETRY.
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach.";
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
Mol. Cell. Proteomics 5:226-233(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-125, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Threonine phosphorylation of the beta 3 integrin cytoplasmic tail, ata site recognized by PDK1 and Akt/PKB in vitro, regulates Shcbinding.";
Kirk R.I., Sanderson M.R., Lerea K.M.;
J. Biol. Chem. 275:30901-30906(2000).
Cited for: PHOSPHORYLATION AT THR-779.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-773, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-773 AND TYR-785, ANDMASS SPECTROMETRY.
"Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIbIIIa) tyrosine phosphorylation induced by platelet aggregation.";
Law D.A., Nannizzi-Alaimo L., Phillips D.R.;
J. Biol. Chem. 271:10811-10815(1996).
Cited for: PHOSPHORYLATION AT TYR-773 AND TYR-785 (ISOFORM BETA-3A).

TOP